CClinicalTrials.gg
TerminatedNCT00221663Updated Aug 15, 2008

Conventional Versus Mini-Sternotomy for Aortic Valve Surgery

A Phase 2/3 interventional study of surgery techniques (sternotomy for aortic valve replacement) in Heart Valve Diseases, sponsored by University Hospital, Bordeaux. Terminated at 1 site in France. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2008-08-15.

Sponsored by University Hospital, Bordeaux · Phase 2/3, Interventional, and Diagnostic

Why this study was terminated
slow recruitment
Phase
Phase 2/3
Study type
Interventional
Enrollment
78
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Study summary

Minimally-invasive operative techniques have been introduced in cardiac surgery. These techniques may have several advantages such as a decrease in post operative pain, lower morbidity and mortality, faster recovery, and a shorter hospital stay. However, these advantages have rarely been documented in the setting of a formal randomized controlled trial.

Read the detailed description

Background:

Minimally invasive techniques for cardiac surgery should be formally evaluated.

Design:

Randomized, single-blind, monocentric trial.

Interventions Compared:

Median sternotomy versus minimally invasive technique.

Eligibility Criteria:

Indication of isolated aortic valvular replacement, preoperative American Society of Anesthesiologists (ASA) class \< = 3, left ventricular ejection fraction > = 40%.

Primary Outcome:

Forced expiratory volume and peak expiratory volume/second at 48 hours.

02

Conditions studied

  • Heart Valve Diseases

Browse trials for

Keywords

  • Cardiac surgery
  • Aortic valve replacement
  • Minimally invasive surgery
  • Perioperative course
03

In context

Heart Valve Diseases

534 studies on the registry are indexed under Heart Valve Diseases; 172 are open to participants now.

This study's enrollment of 78 is below the median of 100 across 290 interventional studies indexed under Heart Valve Diseases.

Browse Heart Valve Diseases studies →

Lead sponsor

University Hospital, Bordeaux is the lead sponsor of 783 studies on the registry; 188 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • Indication of isolated aortic valvular replacement
  • Preoperative ASA class \< = 3
  • Left ventricular ejection fraction > = 40%
  • Signed informed consent

Exclusion criteria

Exclusion Criteria:

  • Aortic or mitral insufficiency > 3
  • History of cardiac surgery
  • Acute pulmonary edema
  • Endocarditis
  • Chronic renal insufficiency decompensation
  • Operative coagulation disorders regardless of etiology
05

Study design

Phase
Phase 2 / Phase 3
Primary purpose
Diagnostic
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Participant)
Enrollment
78 participants (actual)

Interventions

  • Devicesurgery techniques (sternotomy for aortic valve replacement)
06

What researchers measure

Primary outcomes

  1. Forced expiratory volume and peak expiratory volume/second

    Time frame: at 48 hours

Secondary outcomes

  1. Forced expiratory volume

    Time frame: at 24 hours

  2. Peak expiratory volume/s at 24 hours

  3. Pro-inflammatory cytokines on tracheal aspiration samples

  4. Transfusion requirements during the first 24 hours post operative

  5. Hemodynamic parameters

  6. Duration of surgery extracorporeal circulation (ECC) and aortic-cross-clamp-time

  7. Consumption of analgetics

  8. Morbidity and mortality during hospital stay

07

Study locations

1 site
  • Hôpital Cardiologique du Haut Lévêque
    Pessac, 33604, France
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Aug 15, 2008, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT00221663
Lead sponsor
University Hospital, Bordeaux
Collaborators
Ministry of Health, France
First posted
Sep 22, 2005
Start date
Jan 2002
Primary completion
Jan 2002
Completion
Dec 2006
Last update
Aug 15, 2008

Study contacts

Gerard Janvier, Pr
principal investigator · University Hospital, Bordeaux
Joachim Calderon, Dr
principal investigator · University Hospital, Bordeaux France
Geneviéve Chene, Pr
study chair · University Hospital, Bordeaux France

Oversight

Data monitoring committee
Yes
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is terminated, as verified in Aug 2008. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion